The New Frontier in DCIS Risk Assessment
Jun 03, 2025•29 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this episode, host Dr. Reni Butler speaks with Dr. Kalina Slavkova, Dr. Ruya Kang, Dr. Despina Kontos, and Dr. Habib Rahbar about their groundbreaking research using MRI-based radiomic features to improve risk stratification in ductal carcinoma in situ (DCIS). The discussion explores how combining clinical data, imaging, and AI-driven analysis could help personalize treatment and reduce overtreatment in breast cancer care.
MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial). Slavkova and Kang et al. Radiology 2025; 315(1):e241628.For the best experience, listen in Metacast app for iOS or Android